RJ, S., SL, C., S, C., L, M., Y, C., I, L., . . . AT, H. (2024). Oral Everolimus Following Dilation in Idiopathic Subglottic Stenosis: A Phase 1 Nonrandomized Clinical Trial. JAMA otolaryngology-- head & neck surgery, 150(11), 1029. https://doi.org/10.1001/jamaoto.2024.2886
Chicago Style (17th ed.) CitationRJ, So, Collins SL, Collins S, Mafla L, Chan-Li Y, Lina I, Gelbard A, Motz KM, and Hillel AT. "Oral Everolimus Following Dilation in Idiopathic Subglottic Stenosis: A Phase 1 Nonrandomized Clinical Trial." JAMA Otolaryngology-- Head & Neck Surgery 150, no. 11 (2024): 1029. https://doi.org/10.1001/jamaoto.2024.2886.
MLA (9th ed.) CitationRJ, So, et al. "Oral Everolimus Following Dilation in Idiopathic Subglottic Stenosis: A Phase 1 Nonrandomized Clinical Trial." JAMA Otolaryngology-- Head & Neck Surgery, vol. 150, no. 11, 2024, p. 1029, https://doi.org/10.1001/jamaoto.2024.2886.